Background: The knowledge of the potential risk factors associated with implant loss is crucial
implants were significantly related to implant loss, while others had a different view that implant variables including length did not affect the clinical outcome. 7, 8 Moreover, the selection of a short implant or sinus augmentation procedure in the atrophic posterior maxilla was still controversial. Pieri et al conceived that patients who received sinus augmentation surgery or short and diameter-reduced implants in the posterior maxilla had no significant difference than others in terms of failure risk. 9 However, some authors considered that implants shorter than 8 mm should be used with caution because they had a greater risk for failure. 10 Generally, no determinate relationships between potential risk factors and implant loss have been established.
The objective of our study was to analyze the potential risk factors for implant loss in Chinese individuals from Jiangsu province and nearby regions. To the best of our knowledge, there were few studies evaluating implant loss related risk factors in Chinese patients, so our research was necessary for clinical guidance. Meanwhile, our study particularly analyzed implants placed in the maxillary molar location, which would provide more help for making a clinical decision. Due to the rapid growth of materials and techniques in implant design and surgical procedure, patients who received implant surgery at the same clinic within last 2 years were included, ensuring that they were treated with similarly manufactured implants and equal treatment.
| MATERIALS AND METHODS

| Study population
This retrospective cohort study included patients who received dental implant surgeries at Nanjing Stomatological Hospital, Medical School of Nanjing University between January 4th, 2015 and March 20th, 2017. All the included implants must have a follow-up for at least 6 months except for some failed implants. Before surgery, all patients were asked to undergo a blood test and ultrasonic supragingival scaling. Heavy smokers (>20 cigarettes 1 day) and patients with uncontrolled systemic diseases (such as hypertension and diabetes) were excluded to ensure a successful outcome for the implant treatment.
All patients signed informed consent before surgery and all implants were installed by six experienced surgeons according to the manufacturer's guidelines of 12 implant systems and the pre-surgical radiographic outcome. The implant size (length and diameter) and treatment plan were verified based on the condition of each case.
When implants were inserted immediately after tooth extraction, or inserted in maxilla anterior location, bone grafting procedures were usually needed. In addition, implants which needed maxillary sinus floor elevation sometimes required bone grafting procedures simultaneously in posterior maxilla with insufficient bone quantity. Some patients even received bone augmentation and delayed implant placement but they were excluded in our study. All patients were asked to take antibiotics at least 3 days after surgery. The healing time before ultimate restoration was 4 months for patients without bone grafting procedures, and 6 months for those with bone grafting procedures.
During the first year after placement of prostheses, patients were asked to have at least three recall checks (3 months, 6 months, and 12 months, respectively). Then periodic recall check was performed consisted of both clinical and radiological evaluation of the implants.
All patient information collected in our study has been approved by institutional review board (IRB) of Nanjing Stomatological Hospital.
| Related variables
The data of patients were derived from the Department of Implantol- 
| Definition of implant loss
The failed/lost implants were defined as those lost from alveolar bone or those which were removed by surgical extraction in our study. And the survival time was regarded as the period from the date of implant placement to implant loss or to the end of our observation time.
| Statistical analysis
Data for categorical variables were summarized as the frequencies and percentages. Categorical variables among different groups were compared with the chi-square test. The Kaplan-Meier survival analysis method and log-rank test were used for estimating the cumulative survival rates at the implant level. Multivariate Cox regression analysis was performed to identify the probability of implant loss with different predictors. Adjusted hazard ratios (HRs) were presented, which
showed the specific probability of failure compared to the base group.
All statistics were calculated using Python modules "scipy. stats" and "lifelines." Significant differences were confirmed by P < .05.
3 | RESULTS
| Overall clinical outcome
Thirty-three variables and 5069 patients with 9113 implants were initially collected. After date processing, a total of 4338 patients with 6977 implants were finally included in this study, 2063 (47.56%) of whom were men, and 2275 (52.44%) were women. The information on implant brand and surgeon was shown in Supporting Information Figure 1A , and the distribution of the early implant loss and late implant loss was shown in Figure 1B .
| Risk factor analysis in all implants
Chi-square analysis on each discrete random variable was performed to identify the potential risk factors for implant loss (Table 1) . Fiftythree implants lost in females (1.48%) and 94 lost in males (2.76%), which indicating gender was a significant risk factor for implant loss (P < .001). Besides, all implants were divided into two groups (<10 mm or ≥10 mm) based on implant length, in which, 40 failed implants were shorter than 10 mm (2.83%) and 107 failed implants were 10 mm or longer (1.92%), revealing that the association between implant loss and implant length was significant (P < .05). As for implant location, no significant difference was discovered among the six groups. However, the survival rate for maxillary molar implants (1418 implants) was statistically lower than other implants (P < .05). And the remaining variables including age, bone grafting procedure, and implant diameter were not significantly associated with implant loss.
| Risk factor analysis of maxillary molar implants
As maxillary molar implants suffered from higher loss rate than others (Table 1) , chi-square analysis was additionally performed to estimate the risk factors in this location ( 
| Implant survival function analysis
The total cumulative survival rate (CSR) for the included implants was 97.76% with a follow-up period ranged from 0 to 32 months. The survival curves for implants placed in different locations by a KaplanMeier survival curve model were illustrated in Figure 2 . Among them, maxillary molar implants had the lowest CSR (97.00%). Additionally, the survival rate for the maxillary molar implants was significantly lower than that of the other implants, which was determined by the log-rank test ( Figure 2B ). Furthermore, the survival curves for the implants classified by other variables including age, gender, bone grafting procedure, implant length, and diameter, were displayed in Figure 3 . The survival rates for implants inserted in male patients and short implants (<10 mm) were both lower than others (P < .05). There was no significant difference between the non-grafted group and the grafted group, but a sharp decline of the survival rate was shown in grafted group at around 6 months after operation. The survival curves for the maxillary molar implants were shown in Figure 4 , indicating that gender and bone grafting procedure were significant variables.
What's more, most curves manifested a rapid decrease at around 4-6 months and a gentle trend after 6 months, as shown in Figures 3 and 4.
| Hazard ratios of variables related to implant loss
To determine the respective probabilities of implant loss for different variables and to adjust the potential confounding, the variables were assessed by multivariate Cox regression analysis. For all implants, gender and implant length (≥10 mm or not) were concluded as significant (Table 3) . Furthermore, the results showed the loss risk for males was 1.90 times higher than that for females (P < .001). And the loss risk for long implants (≥10 mm) was 0.76 times compared with other implants (P < .05). However, the related risk factors for maxillary molar implants were slightly different from those for the whole implants (Table 4) . Gender and bone grafting procedure were found that they affected the outcome significantly.
The implant loss risk for males was 2.08 times higher than that for females (P < .05). And implants with bone grafting procedure had a 2.33 times higher risk for loss (P < .01) compared with implants without bone grafting procedure.
| DISCUSSION
The implant loss rate in this retrospective study was 2.11% and lower than other previous studies with longer follow-up period. 4, 11 Due to the own traits of each case in clinical work of implantology, it was considered that a multifactorial etiology would lead to implant loss. 12 As for participant variables, including gender and age, a higher failure risk was discovered in males than in females, which was in accordance with previous findings. 5, 6 In contrary, no significant difference of survival rates was detected between groups classified with age in our study, suggesting that age was not able to be a latent risk factor for implant loss.
Implant location was also considered as one of the risk factors for implant loss, but the opinions were controversial in diverse locations, such as mandibular anterior, mandibular posterior, or maxillary posterior locations. 6, 13 However, as maxillary premolar location hardly had insufficient vertical bone volume for implant placement, all implants were divided into six subgroups instead of two (maxilla and mandibula) or four (anterior/posterior maxilla, anterior/posterior mandibula) groups to analyze the influence of implant location on implant loss in our study. 6, 7 The cumulative survival rate for maxillary molar implants was the lowest (96.09%) compared with other groups, which indicating that the maxillary molar location could be considered as a risk factor for implant loss. This phenomenon might be attributed to the lower bone quality (score 3-4), insufficient bone volume and higher bite force in the maxillary molar location. 8, 14, 15 Due to the insufficient bone volume caused by the expanded maxillary sinus, bone grafting procedures were sometimes needed, especially in an atrophic posterior maxilla with a 4 mm or less residual crestal bone height. 14, 16 Meanwhile, the cumulative survival rates for maxillary molar implants were significantly different between the grafted (94.98%) and non-grafted (97.89%) groups, demonstrating that the bone grafting procedure could be one of the risk factors for maxillary molar implant loss. Furthermore, the bite force in the posterior jaw was about three times than that in the anterior location, thus for length <10 mm in red line). E, CSRs according to implant diameter (97.93% for implant diameter <4.5 mm in blue line and 97.56% for diameter ≥4.5 mm in red line). Significant differences were shown in gender and implant length according to log-rank test implants in maxillary molar location might suffer from higher risk of osseointegration loss. 15 Except for implant location, implant length was considered as a risk factor for implant loss as well. 8 Our results revealed that the cumulative survival rate for implants shorter than 10 mm (96.93%) was significantly lower than longer implants (97.97%), which reason might be the disadvantage of initial stability and the increased risk for micromotion during healing period for short implants. 17 However, short implants (<10 mm) did not perform a higher loss rate in maxillary molar location in our study, so that the application of short implants (<10 mm) could be an option for patients with mild atrophic posterior maxilla, which offered a less complex, cheaper and faster way to replace sinus floor elevation. 18 Moreover, implant diameter was another potential risk factor related to implant loss. Some authors reported a higher loss rate for implant with a large diameter (>5 mm), 19 and others reported that early implant loss was related to a narrow diameter of implants. 20 Nevertheless, implant diameter was not a risk factor for implant loss according to our results, which was consistent with some studies. 1, 5 Furthermore, it was noteworthy that most survival curves had two rapid decreases. One was within the first month, the other was around the 5-6th month after operation. Except for the acute infection in the first month, most failed implants were removed because of poor osseointegration that would not induce abnormal sensations before permanent restoration 5-6 months after the operation, which might result in the tendency of the survival curves. Beyond that, more failed implants were removed within 6 months (62.59%) and mainly within 1 year (93.2%), and 80% of the lost implants belonged to early implant loss, revealing that it was important to reduce the risks of early infection and defective osseointegration through standard surgical procedures. In addition to the variables we studied, some other factors have been reportedly related to implant loss, such as smoking habits, diabetes, and periodontal status. 21 These variables were not demonstrated because of the incomplete information, and this was one of the weaknesses of this study. Additionally, all implants included in this study were inserted after 2015, and this resulted in a rather short follow-up period (most being within 2 years). Thus, further studies are required to explore more risk factors for implant loss and to observe the long-term stability of dental implants.
| CONCLUSION
In summary, the cumulative survival rate for 6977 implants inserted in 4338 patients was 97.11% after 0-32 months of observation period.
Our results suggested that male sex, shorter implants (<10 mm) and the maxillary molar location were potential risk factors for implant loss in all implants, whereas male sex and implants with bone grafting procedures significantly increased the risk for loss in maxillary molar implants.
